Connor Clark & Lunn Investment Management Ltd. Takes $817,000 Position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 157,102 shares of the company's stock, valued at approximately $817,000. Connor Clark & Lunn Investment Management Ltd. owned about 0.08% of Aveanna Healthcare at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Renaissance Technologies LLC lifted its stake in Aveanna Healthcare by 155.8% in the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company's stock valued at $438,000 after buying an additional 96,600 shares in the last quarter. Acadian Asset Management LLC lifted its stake in Aveanna Healthcare by 176.6% during the second quarter. Acadian Asset Management LLC now owns 81,275 shares of the company's stock worth $222,000 after purchasing an additional 51,890 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Aveanna Healthcare by 1.8% in the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company's stock valued at $6,402,000 after purchasing an additional 44,970 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at about $101,000. Finally, Mackenzie Financial Corp increased its stake in shares of Aveanna Healthcare by 35.9% during the second quarter. Mackenzie Financial Corp now owns 45,674 shares of the company's stock worth $126,000 after buying an additional 12,075 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on AVAH shares. Royal Bank of Canada boosted their target price on Aveanna Healthcare from $3.00 to $5.00 and gave the company a "sector perform" rating in a report on Friday, August 9th. UBS Group raised their price objective on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the company a "sell" rating in a research report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a "buy" rating in a report on Friday, August 9th.

Aveanna Healthcare Stock Up 4.1 %

Shares of Aveanna Healthcare stock traded up $0.23 during trading hours on Friday, hitting $5.81. 122,821 shares of the company's stock traded hands, compared to its average volume of 200,658. The stock has a 50 day simple moving average of $5.22 and a 200-day simple moving average of $4.25. Aveanna Healthcare Holdings Inc. has a twelve month low of $2.00 and a twelve month high of $6.19.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. The company had revenue of $509.02 million for the quarter, compared to analyst estimates of $495.80 million. During the same quarter in the previous year, the company posted ($0.05) earnings per share. As a group, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current fiscal year.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.